The Latest Clinical Advances in Thrombocytopenia
Platelets are critical elements in the blood stream, supporting hemostasis (defense against bleeding), as well as performing even more complex tasks within networks of biological (immunity) and pathophysiological processes, such as cancer and ischemia/reperfusion injury. Changes in the number (and f...
Spremljeno u:
| Format: | Online |
|---|---|
| Jezik: | engleski |
| Izdano: |
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Teme: | |
| Online pristup: | ONIX_20220224_9783036528052_16 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
| _version_ | 1869514359423631360 |
|---|---|
| collection | Directory of Open Access Books |
| description | Platelets are critical elements in the blood stream, supporting hemostasis (defense against bleeding), as well as performing even more complex tasks within networks of biological (immunity) and pathophysiological processes, such as cancer and ischemia/reperfusion injury. Changes in the number (and function) of platelets may have a substantial impact on any of these processes. The “simple” finding of a reduced platelet count (thrombocytopenia) has a history (origin) and a consequence (e.g., bleeding). This book brings together international experts to provide an up-to-date overview of the impact of thrombocytopenia from a clinical perspective. |
| format | Online |
| id | doab-20.500.12854ir-78718 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2022 |
| publishDateRange | 2022 |
| publishDateSort | 2022 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-787182024-03-30T23:21:37Z The Latest Clinical Advances in Thrombocytopenia ten Cate, Hugo Lammle, Bernhard thrombotic thrombocytopenic purpura depression resilience quality of life inherited thrombocytopenias platelets bleeding TTP ADAMTS13 treatment diagnosis follow-up review caplacizumab pseudothrombocytopenia hematimetry fluorescence amikacin anticoagulants COVID-19 platelet thrombocytopenia cardiac surgery inflammation biological prosthesis extracorporeal life support heparin-induced thrombocytopenia (HIT) new concepts pathogenesis management immune PF4/heparin/antibody complexes Bayesian diagnostic thinking therapeutic plasma exchange intravenous immunoglobulins (IVIG) immune thrombocytopenia platelet destruction immune tolerance megakaryocytes ITP treatment virus infection thrombocytopathy aggregation HIV SARS-CoV-2 hantavirus coronavirus influenza platelet disorders procoagulant platelets activation endpoints myelodysplastic syndromes (MDS) bone marrow failure (BMF) syndromes aplastic anemia (AA) next-generation sequencing (NGS) platelet function tests platelet count flow cytometry anticoagulation antifibrinolytic antiplatelet cancer thrombopoietin receptor agonist tranexamic acid advanced liver disease bleeding risk cirrhosis hemostasis thrombopoietin receptor agonists/mimetics platelet transfusion guidelines platelet transfusion alternatives platelet additive solutions platelet pathogen inactivation/reduction cold stored platelet concentrates n/a thema EDItEUR::M Medicine and Nursing Platelets are critical elements in the blood stream, supporting hemostasis (defense against bleeding), as well as performing even more complex tasks within networks of biological (immunity) and pathophysiological processes, such as cancer and ischemia/reperfusion injury. Changes in the number (and function) of platelets may have a substantial impact on any of these processes. The “simple” finding of a reduced platelet count (thrombocytopenia) has a history (origin) and a consequence (e.g., bleeding). This book brings together international experts to provide an up-to-date overview of the impact of thrombocytopenia from a clinical perspective. 2022-02-24T10:34:03Z 2022-02-24T10:34:03Z 2022 book ONIX_20220224_9783036528052_16 9783036528052 9783036528045 https://directory.doabooks.org/handle/20.500.12854/78718 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/4809 https://mdpi.com/books/pdfview/book/4809 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-2805-2 10.3390/books978-3-0365-2805-2 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036528052 9783036528045 312 Basel open access |
| spellingShingle | thrombotic thrombocytopenic purpura depression resilience quality of life inherited thrombocytopenias platelets bleeding TTP ADAMTS13 treatment diagnosis follow-up review caplacizumab pseudothrombocytopenia hematimetry fluorescence amikacin anticoagulants COVID-19 platelet thrombocytopenia cardiac surgery inflammation biological prosthesis extracorporeal life support heparin-induced thrombocytopenia (HIT) new concepts pathogenesis management immune PF4/heparin/antibody complexes Bayesian diagnostic thinking therapeutic plasma exchange intravenous immunoglobulins (IVIG) immune thrombocytopenia platelet destruction immune tolerance megakaryocytes ITP treatment virus infection thrombocytopathy aggregation HIV SARS-CoV-2 hantavirus coronavirus influenza platelet disorders procoagulant platelets activation endpoints myelodysplastic syndromes (MDS) bone marrow failure (BMF) syndromes aplastic anemia (AA) next-generation sequencing (NGS) platelet function tests platelet count flow cytometry anticoagulation antifibrinolytic antiplatelet cancer thrombopoietin receptor agonist tranexamic acid advanced liver disease bleeding risk cirrhosis hemostasis thrombopoietin receptor agonists/mimetics platelet transfusion guidelines platelet transfusion alternatives platelet additive solutions platelet pathogen inactivation/reduction cold stored platelet concentrates n/a thema EDItEUR::M Medicine and Nursing The Latest Clinical Advances in Thrombocytopenia |
| title | The Latest Clinical Advances in Thrombocytopenia |
| title_full | The Latest Clinical Advances in Thrombocytopenia |
| title_fullStr | The Latest Clinical Advances in Thrombocytopenia |
| title_full_unstemmed | The Latest Clinical Advances in Thrombocytopenia |
| title_short | The Latest Clinical Advances in Thrombocytopenia |
| title_sort | latest clinical advances in thrombocytopenia |
| topic | thrombotic thrombocytopenic purpura depression resilience quality of life inherited thrombocytopenias platelets bleeding TTP ADAMTS13 treatment diagnosis follow-up review caplacizumab pseudothrombocytopenia hematimetry fluorescence amikacin anticoagulants COVID-19 platelet thrombocytopenia cardiac surgery inflammation biological prosthesis extracorporeal life support heparin-induced thrombocytopenia (HIT) new concepts pathogenesis management immune PF4/heparin/antibody complexes Bayesian diagnostic thinking therapeutic plasma exchange intravenous immunoglobulins (IVIG) immune thrombocytopenia platelet destruction immune tolerance megakaryocytes ITP treatment virus infection thrombocytopathy aggregation HIV SARS-CoV-2 hantavirus coronavirus influenza platelet disorders procoagulant platelets activation endpoints myelodysplastic syndromes (MDS) bone marrow failure (BMF) syndromes aplastic anemia (AA) next-generation sequencing (NGS) platelet function tests platelet count flow cytometry anticoagulation antifibrinolytic antiplatelet cancer thrombopoietin receptor agonist tranexamic acid advanced liver disease bleeding risk cirrhosis hemostasis thrombopoietin receptor agonists/mimetics platelet transfusion guidelines platelet transfusion alternatives platelet additive solutions platelet pathogen inactivation/reduction cold stored platelet concentrates n/a thema EDItEUR::M Medicine and Nursing |
| topic_facet | thrombotic thrombocytopenic purpura depression resilience quality of life inherited thrombocytopenias platelets bleeding TTP ADAMTS13 treatment diagnosis follow-up review caplacizumab pseudothrombocytopenia hematimetry fluorescence amikacin anticoagulants COVID-19 platelet thrombocytopenia cardiac surgery inflammation biological prosthesis extracorporeal life support heparin-induced thrombocytopenia (HIT) new concepts pathogenesis management immune PF4/heparin/antibody complexes Bayesian diagnostic thinking therapeutic plasma exchange intravenous immunoglobulins (IVIG) immune thrombocytopenia platelet destruction immune tolerance megakaryocytes ITP treatment virus infection thrombocytopathy aggregation HIV SARS-CoV-2 hantavirus coronavirus influenza platelet disorders procoagulant platelets activation endpoints myelodysplastic syndromes (MDS) bone marrow failure (BMF) syndromes aplastic anemia (AA) next-generation sequencing (NGS) platelet function tests platelet count flow cytometry anticoagulation antifibrinolytic antiplatelet cancer thrombopoietin receptor agonist tranexamic acid advanced liver disease bleeding risk cirrhosis hemostasis thrombopoietin receptor agonists/mimetics platelet transfusion guidelines platelet transfusion alternatives platelet additive solutions platelet pathogen inactivation/reduction cold stored platelet concentrates n/a thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20220224_9783036528052_16 |